Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-018642
Filing Date
2016-05-09
Accepted
2016-05-09 17:15:50
Documents
74
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q clvs-10q_20160331.htm 10-Q 1640301
2 EX-10.36 clvs-ex1036_743.htm EX-10.36 15905
3 EX-10.37 clvs-ex1037_742.htm EX-10.37 5151
4 EX-31.1 clvs-ex311_8.htm EX-31.1 16916
5 EX-31.2 clvs-ex312_9.htm EX-31.2 16816
6 EX-32.1 clvs-ex321_6.htm EX-32.1 4272
7 EX-32.2 clvs-ex322_7.htm EX-32.2 4557
  Complete submission text file 0001564590-16-018642.txt   6194089

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT clvs-20160331.xml EX-101.INS 1349671
9 XBRL TAXONOMY EXTENSION SCHEMA clvs-20160331.xsd EX-101.SCH 45253
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clvs-20160331_cal.xml EX-101.CAL 44645
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clvs-20160331_def.xml EX-101.DEF 128043
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20160331_lab.xml EX-101.LAB 363801
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20160331_pre.xml EX-101.PRE 276327
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

EIN.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 161632707
SIC: 2834 Pharmaceutical Preparations